Histiocytic Sarcoma: Challenging Course, Dismal Outcome
Sign Up to like & getrecommendations! Published in 2021 at "Diagnostics"
DOI: 10.3390/diagnostics11020310
Abstract: Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution.… read more here.
Keywords: sarcoma; challenging course; histiocytic sarcoma; sarcoma challenging ... See more keywords